AMETEK Posts Record Q2 2026 Results, Raises Full-Year Guidance
Event summary
- Q2 2026 sales hit $2.04B, up 15% YoY; adjusted EPS rose 17% to $2.09.
- Operating margins expanded by 60 basis points to 26.6%, with free cash flow conversion at 111%.
- Electronic Instruments Group (EIG) sales grew 14%; Electromechanical Group (EMG) saw 17% growth.
- Full-year guidance raised: adjusted EPS now projected at $8.20–$8.30, up from prior $7.94–$8.14 range.
The big picture
AMETEK's strong Q2 results reflect its disciplined execution of the AMETEK Growth Model, leveraging operational excellence and strategic acquisitions. The company's position as a mission-critical provider in secular growth markets like global infrastructure underscores its resilience amid broader industrial trends.
What we're watching
- Execution Risk
- Whether AMETEK can sustain its high-teens earnings growth amid rising acquisition costs.
- Market Dynamics
- How semiconductor and commercial aerospace demand will impact EIG's performance.
- Strategic Expansion
- The pace at which EMG can maintain its 290-basis-point core margin expansion in medtech, defense, and automation markets.
Related topics